New features of NeuroMetrix’ Quell Wearable Pain Relief Technology, unveiled during CES 2017, include enhanced personalization and health tracking capabilities.

“With chronic pain impacting so many people, we look forward to building awareness of alternative treatments among CES attendees and more broadly the chronic pain community,” says Shai N. Gozani, MD, PhD, president and CEO of NeuroMetrix, in a media release.

“We are eager to introduce our most advanced technology features at the show, which were specifically designed to help our users better manage their pain, so they can get back to living their lives.”

According to the release, the Quell technology now offers users the ability to calibrate their devices using the Quell app; provides customized therapy dosage and responsive therapy at night; and the ability to track multiple health dimensions including pain, activity, and gait.

The technology also delivers up to a 40% improvement in battery life, and is capable of remote upgrades.

NeuroMetrix Inc, headquartered in Waltham, Mass, was founded as a spinoff from the Harvard-MIT Division of Health Sciences and Technology in 1996.

[Source(s): NeuroMetrix Inc, Business Wire]